August 30, 2016 6:16 PM ET

Biotechnology

Company Overview of Diartis Pharmaceuticals, Inc.

Company Overview

Diartis Pharmaceuticals, Inc., a biopharmaceutical company, develops therapeutic proteins for the treatment of metabolic disorders. Its development portfolio includes VRS-859, a glucagon-like peptide-1 analog that provides improved therapeutic outcomes for Type 2 diabetic patients. The company was incorporated in 2010 and is based in Redwood City, California.

275 Shoreline Drive

Suite 450

Redwood City, CA 94065

United States

Founded in 2010

Phone:

650-963-8595

Key Executives for Diartis Pharmaceuticals, Inc.

Founder, Chief Executive Officer and Director
Age: 51
Senior Vice President of Business Development
Age: 48
Clinical Advisor
Compensation as of Fiscal Year 2016.

Similar Private Companies By Industry

Company Name Region
20n Labs, Inc. United States
23andMe, Inc. United States
2C Tech Corporation, Inc. United States
3-V Biosciences, Inc. United States
3D Bio Holdings LLC United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Bloomberg L.P. United States
NYC2012, Inc. United States
Rush University United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Diartis Pharmaceuticals, Inc., please visit www.diartispharma.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.